88 related articles for article (PubMed ID: 26499077)
21. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.
Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Croteau DL; Moseley PM; Hameed K; Green A; Aleskandarany MA; Rakha EA; Patterson K; Ball G; Chan SY; Ellis IO; Bohr VA; Bryant HE; Madhusudan S
Carcinogenesis; 2016 Jan; 37(1):63-71. PubMed ID: 26586793
[TBL] [Abstract][Full Text] [Related]
23. Mining the role of RECQL5 in gastric cancer and seeking potential regulatory network by bioinformatics analysis.
Lin Y; Chen H; Wang X; Xiang J; Wang H; Peng J
Exp Mol Pathol; 2020 Aug; 115():104477. PubMed ID: 32497619
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of osteosarcoma cell progression by MacroH2A via the downregulation of cyclin D and cyclin‑dependent kinase genes.
Yang P; Yin K; Zhong D; Liao Q; Li K
Mol Med Rep; 2015 Mar; 11(3):1905-10. PubMed ID: 25378143
[TBL] [Abstract][Full Text] [Related]
25. Tumor-suppressing effects of miR451 in human osteosarcoma.
Xu H; Mei Q; Shi L; Lu J; Zhao J; Fu Q
Cell Biochem Biophys; 2014 May; 69(1):163-8. PubMed ID: 24218283
[TBL] [Abstract][Full Text] [Related]
26. RECQL5 at the
Hamadeh Z; Lansdorp P
Front Cell Dev Biol; 2020; 8():324. PubMed ID: 32523948
[TBL] [Abstract][Full Text] [Related]
27. Insights into the RecQ helicase mechanism revealed by the structure of the helicase domain of human RECQL5.
Newman JA; Aitkenhead H; Savitsky P; Gileadi O
Nucleic Acids Res; 2017 Apr; 45(7):4231-4243. PubMed ID: 28100692
[TBL] [Abstract][Full Text] [Related]
28. Human RECQL5 participates in the removal of endogenous DNA damage.
Tadokoro T; Ramamoorthy M; Popuri V; May A; Tian J; Sykora P; Rybanska I; Wilson DM; Croteau DL; Bohr VA
Mol Biol Cell; 2012 Nov; 23(21):4273-85. PubMed ID: 22973052
[TBL] [Abstract][Full Text] [Related]
29. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.
Du JY; Wang LF; Wang Q; Yu LD
Oncol Rep; 2015 Apr; 33(4):1890-8. PubMed ID: 25672572
[TBL] [Abstract][Full Text] [Related]
30. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
Xie XK; Yang DS; Ye ZM; Tao HM
Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
[TBL] [Abstract][Full Text] [Related]
31. [Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcoma cell lines MG-63 and U2OS].
Xie XK; Yang DS; Ye ZM; Tao HM
Ai Zheng; 2005 Mar; 24(3):292-7. PubMed ID: 15757529
[TBL] [Abstract][Full Text] [Related]
32. Targeting RECQL5 Functions, by a Small Molecule, Selectively Kills Breast Cancer
Chakraborty S; Dutta K; Gupta P; Das A; Das A; Ghosh SK; Patro BS
J Med Chem; 2021 Feb; 64(3):1524-1544. PubMed ID: 33529023
[TBL] [Abstract][Full Text] [Related]
33. MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation.
Xu J; Yao Q; Hou Y; Xu M; Liu S; Yang L; Zhang L; Xu H
Biomed Pharmacother; 2013 Jun; 67(5):381-6. PubMed ID: 23601845
[TBL] [Abstract][Full Text] [Related]
34. Molecular defect of RAPADILINO syndrome expands the phenotype spectrum of RECQL diseases.
Siitonen HA; Kopra O; Kääriäinen H; Haravuori H; Winter RM; Säämänen AM; Peltonen L; Kestilä M
Hum Mol Genet; 2003 Nov; 12(21):2837-44. PubMed ID: 12952869
[TBL] [Abstract][Full Text] [Related]
35. The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway.
Duan DP; Dang XQ; Wang KZ; Wang YP; Zhang H; You WL
Oncol Rep; 2012 Nov; 28(5):1693-700. PubMed ID: 22922684
[TBL] [Abstract][Full Text] [Related]
36. MEF2D overexpression contributes to the progression of osteosarcoma.
Yu H; Sun H; Bai Y; Han J; Liu G; Liu Y; Zhang N
Gene; 2015 Jun; 563(2):130-5. PubMed ID: 25814384
[TBL] [Abstract][Full Text] [Related]
37. Distinct prognosis of mRNA expression of the five RecQ DNA-helicase family members -
Zhu X; Chen H; Yang Y; Xu C; Zhou J; Zhou J; Chen Y
Cancer Manag Res; 2018; 10():6649-6668. PubMed ID: 30584360
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells.
Salvatori L; Caporuscio F; Coroniti G; Starace G; Frati L; Russo MA; Petrangeli E
J Cell Physiol; 2009 Jul; 220(1):35-44. PubMed ID: 19347870
[TBL] [Abstract][Full Text] [Related]
39. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage.
Liu Z; Liu Q; Xu B; Wu J; Guo C; Zhu F; Yang Q; Gao G; Gong Y; Shao C
Mutat Res; 2009 Mar; 662(1-2):75-83. PubMed ID: 19159633
[TBL] [Abstract][Full Text] [Related]
40. Effect of Recql5 deficiency on the intestinal tumor susceptibility of Apc(min) mice.
Hu Y; Lu X; Luo G
World J Gastroenterol; 2010 Mar; 16(12):1482-6. PubMed ID: 20333788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
